The resulting degree of LGI assessed by circulating biomarkers such as IL-6 and hs-CRP predicts the onset of T2D years before the development of overt hyperglycemia, sustaining its role in the pathogenesis of the disease. This evidence concerns the gene IL6 and type 2 diabetes mellitus.